{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:58:00Z","timestamp":1767859080138,"version":"3.49.0"},"reference-count":215,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/QUI\/00313\/2019"],"award-info":[{"award-number":["UID\/QUI\/00313\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/137991\/2018"],"award-info":[{"award-number":["SFRH\/BD\/137991\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/QUI\/00313\/2019"],"award-info":[{"award-number":["UID\/QUI\/00313\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/137991\/2018"],"award-info":[{"award-number":["SFRH\/BD\/137991\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Protein aggregation and subsequent accumulation of insoluble amyloid fibrils with cross-\u03b2 structure is an intrinsic characteristic of amyloid diseases, i.e., amyloidoses. Amyloid formation involves a series of on-pathway and off-pathway protein aggregation events, leading to mature insoluble fibrils that eventually accumulate in multiple tissues. In this cascade of events, soluble oligomeric species are formed, which are among the most cytotoxic molecular entities along the amyloid cascade. The direct or indirect action of these amyloid soluble oligomers and amyloid protofibrils and fibrils in several tissues and organs lead to cell death in some cases and organ disfunction in general. There are dozens of different proteins and peptides causing multiple amyloid pathologies, chief among them Alzheimer\u2019s, Parkinson\u2019s, Huntington\u2019s, and several other neurodegenerative diseases. Amyloid fibril disassembly is among the disease-modifying therapeutic strategies being pursued to overcome amyloid pathologies. The clearance of preformed amyloids and consequently the arresting of the progression of organ deterioration may increase patient survival and quality of life. In this review, we compiled from the literature many examples of chemical and biochemical agents able to disaggregate preformed amyloids, which have been classified as molecular chaperones, chemical chaperones, and pharmacological chaperones. We focused on their mode of action, chemical structure, interactions with the fibrillar structures, morphology and toxicity of the disaggregation products, and the potential use of disaggregation agents as a treatment option in amyloidosis.<\/jats:p>","DOI":"10.3390\/biomedicines10123276","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T07:27:30Z","timestamp":1671434850000},"page":"3276","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Amyloid Disassembly: What Can We Learn from Chaperones?"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4097-2766","authenticated-orcid":false,"given":"Zaida L.","family":"Almeida","sequence":"first","affiliation":[{"name":"Chemistry Department and Coimbra Chemistry Centre\u2014Institute of Molecular Sciences (CQC-IMS), University of Coimbra, 3004-535 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9128-2557","authenticated-orcid":false,"given":"Rui M. M.","family":"Brito","sequence":"additional","affiliation":[{"name":"Chemistry Department and Coimbra Chemistry Centre\u2014Institute of Molecular Sciences (CQC-IMS), University of Coimbra, 3004-535 Coimbra, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Almeida, Z.L., and Brito, R.M.M. (2020). Structure and Aggregation Mechanisms in Amyloids. Molecules, 25.","DOI":"10.3390\/molecules25051195"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nnano.2010.59","article-title":"Understanding amyloid aggregation by statistical analysis of atomic force microscopy images","volume":"5","author":"Adamcik","year":"2010","journal-title":"Nat. Nanotechnol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.abm7285","article-title":"Cryo-EM structures of amyloid-\u03b2 42 filaments from human brains","volume":"375","author":"Yang","year":"2022","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of \u03b1-synuclein filaments from multiple system atrophy","volume":"585","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13038-z","article-title":"Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis","volume":"10","author":"Schmidt","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.molmed.2020.01.005","article-title":"Chemical Chaperones as Novel Drugs for Parkinson\u2019s Disease","volume":"26","author":"Pujols","year":"2020","journal-title":"Trends Mol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1039\/C7TB02538F","article-title":"Tanshinones inhibit hIAPP aggregation, disaggregate preformed hIAPP fibrils, and protect cultured cells","volume":"6","author":"Ren","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4062\/biomolther.2019.113","article-title":"Polyphenolic biflavonoids inhibit amyloid-beta fibrillation and disaggregate preformed amyloid-beta fibrils","volume":"28","author":"Choi","year":"2020","journal-title":"Biomol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"109077","DOI":"10.1016\/j.abb.2021.109077","article-title":"Inhibition and disruption of amyloid formation by the antibiotic levofloxacin: A new direction for antibiotics in an era of multi-drug resistance","volume":"714","author":"Khan","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1021\/acs.jafc.1c06918","article-title":"Inhibition of Islet Amyloid Polypeptide Fibrillation by Structurally Diverse Phenolic Compounds and Fibril Disaggregation Potential of Rutin and Quercetin","volume":"70","author":"Abioye","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1570164617999200729161846","article-title":"Inhibitory as well as Disaggregation Potential of Selected Hydroxy Benzoic Phytochemicals on Hen Egg-White Lysozyme Amyloidogenesis","volume":"18","author":"Mandal","year":"2021","journal-title":"Curr. Proteomics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature18965","article-title":"Structural basis for the antifolding activity of a molecular chaperone","volume":"537","author":"Huang","year":"2016","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fnins.2017.00185","article-title":"Protein quality control by molecular chaperones in neurodegeneration","volume":"11","author":"Ciechanover","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fnmol.2017.00098","article-title":"Chaperones as suppressors of protein misfolded oligomer toxicity","volume":"10","author":"Mannini","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jare.2021.05.007","article-title":"Molecular mechanisms of amyloid disaggregation","volume":"36","author":"Low","year":"2022","journal-title":"J. Adv. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/02656730500384248","article-title":"Inducers and co-inducers of molecular chaperones","volume":"21","author":"Ohtsuka","year":"2005","journal-title":"Int. J. Hyperth."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Shorter, J. (2011). The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026319"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/emboj\/16.7.1501","article-title":"Substrate specificity of the DnaK chaperone determined by screening cellulose-bound peptide libraries","volume":"16","author":"Germeroth","year":"1997","journal-title":"EMBO J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fmolb.2015.00057","article-title":"Metazoan Hsp70-based protein disaggregases: Emergence and mechanisms","volume":"2","author":"Nillegoda","year":"2015","journal-title":"Front. Mol. Biosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e24560","DOI":"10.7554\/eLife.24560","article-title":"Evolution of an intricate J-protein network driving protein disaggregation in eukaryotes","volume":"6","author":"Nillegoda","year":"2017","journal-title":"Elife"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Duennwald, M.L., Echeverria, A., and Shorter, J. (2012). Small Heat Shock Proteins Potentiate Amyloid Dissolution by Protein Disaggregases from Yeast and Humans. PLoS Biol., 10.","DOI":"10.1371\/journal.pbio.1001346"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.molcel.2015.07.012","article-title":"Human Hsp70 Disaggregase Reverses Parkinson\u2019s-Linked \u03b1-Synuclein Amyloid Fibrils","volume":"59","author":"Gao","year":"2015","journal-title":"Mol. Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.15252\/embj.201797212","article-title":"Complete suppression of Htt fibrilization and disaggregation of Htt fibrils by a trimeric chaperone complex","volume":"37","author":"Scior","year":"2018","journal-title":"EMBO J."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ferrari, L., Geerts, W.J.C., van Wezel, M., Kos, R., Konstantoulea, A., van Bezouwen, L.S., F\u00f6rster, F.G., and R\u00fcdiger, S.G.D. (2018). Human chaperones untangle fibrils of the Alzheimer protein Tau. bioRxiv, 426650.","DOI":"10.1101\/426650"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9676","DOI":"10.1074\/jbc.RA120.013478","article-title":"Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species","volume":"295","author":"Nachman","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature14884","article-title":"Crucial HSP70 co-chaperone complex unlocks metazoan protein disaggregation","volume":"524","author":"Nillegoda","year":"2015","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41594-018-0057-1","article-title":"Mapping interactions with the chaperone network reveals factors that protect against tau aggregation","volume":"25","author":"Mok","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e103954","DOI":"10.15252\/embj.2019103954","article-title":"The HSP110\/HSP70 disaggregation system generates spreading-competent toxic \u03b1-synuclein species","volume":"39","author":"Tittelmeier","year":"2020","journal-title":"EMBO J."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Carlomagno, Y., Zhang, Y., Davis, M., Lin, W.L., Cook, C., Dunmore, J., Tay, W., Menkosky, K., Cao, X., and Petrucelli, L. (2014). Casein kinase II induced polymerization of soluble TDP-43 into filaments is inhibited by heat shock proteins. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090452"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ali, Y.O., Allen, H.M., Yu, L., Li-Kroeger, D., Bakhshizadehmahmoudi, D., Hatcher, A., McCabe, C., Xu, J., Bjorklund, N., and Taglialatela, G. (2016). NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies. PLOS Biol., 14.","DOI":"10.1371\/journal.pbio.1002472"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/cr.2014.46","article-title":"Structural insights into the TRIM family of ubiquitin E3 ligases","volume":"24","author":"Li","year":"2014","journal-title":"Cell Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1515\/hsz-2019-0158","article-title":"Emerging RNA-binding roles in the TRIM family of ubiquitin ligases","volume":"400","author":"Williams","year":"2019","journal-title":"Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"108418","DOI":"10.1016\/j.celrep.2020.108418","article-title":"TRIM11 Prevents and Reverses Protein Aggregation and Rescues a Mouse Model of Parkinson\u2019s Disease","volume":"33","author":"Zhu","year":"2020","journal-title":"Cell Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molcel.2014.04.030","article-title":"A cellular system that degrades misfolded proteins and protects against neurodegeneration","volume":"55","author":"Guo","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_36","first-page":"3","article-title":"The cerebrospinal fluid and barriers\u2014Anatomic and physiologic considerations","volume":"Volume 146","author":"Tumani","year":"2017","journal-title":"Handbook of Clinical Neurology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1002\/elps.200500292","article-title":"Prostaglandin D2 synthase and its post-translational modifications in neurological disorders","volume":"26","author":"Lescuyer","year":"2005","journal-title":"Electrophoresis"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"17949","DOI":"10.1073\/pnas.0608581103","article-title":"Lipocalin-type prostaglandin D syntase produces prostaglandin D2 involved in regulation of physiological sleep","volume":"103","author":"Qu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1073\/pnas.0701585104","article-title":"Lipocalin-type prostaglandin D synthase\/\u03b2-trace is a major amyloid \u03b2-chaperone in human cerebrospinal fluid","volume":"104","author":"Kanekiyo","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-48819-5","article-title":"Abundant neuroprotective chaperone Lipocalin-type prostaglandin D synthase (L-PGDS) disassembles the Amyloid-\u03b2 fibrils","volume":"9","author":"Kannaian","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"13914","DOI":"10.1021\/bi961302+","article-title":"Point Substitution in the Central Hydrophobic Cluster of a Human-Amyloid Congener Disrupts Peptide Folding and Abolishes Plaque Competence","volume":"35","author":"Esler","year":"1996","journal-title":"Biochemistry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000008156","article-title":"Age-dependent change in the levels of A\u03b240 and A\u03b242 in cerebrospinal fluid from control subjects, and a decrease in the ratio of A\u03b242 to A\u03b240 level in cerebrospinal fluid from Alzheimer\u2019s disease patients","volume":"43","author":"Fukuyama","year":"2000","journal-title":"Eur. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molbrainres.2003.08.005","article-title":"Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer\u2019s disease","volume":"118","author":"Puchades","year":"2003","journal-title":"Mol. Brain Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JAD-2009-0966","article-title":"Reduced levels of amyloid-\u03b2-binding proteins in cerebrospinal fluid from Alzheimer\u2019s disease patients","volume":"16","author":"Hansson","year":"2009","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Frangolho, A., Correia, B.E., Vaz, D.C., Almeida, Z.L., and Brito, R.M.M. (2020). Oligomerization Profile of Human Transthyretin Variants with Distinct Amyloidogenicity. Molecules, 25.","DOI":"10.3390\/molecules25235698"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ferreira, E., Almeida, Z.L., Cruz, P.F., Silva e Sousa, M., Ver\u00edssimo, P., and Brito, R.M.M. (2021). Searching for the Best Transthyretin Aggregation Protocol to Study Amyloid Fibril Disruption. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010391"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"27207","DOI":"10.1074\/jbc.M101024200","article-title":"Tetramer Dissociation and Monomer Partial Unfolding Precedes Protofibril Formation in Amyloidogenic Transthyretin Variants","volume":"276","author":"Quintas","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1021\/bi049621l","article-title":"Transthyretin aggregation under partially denaturing conditions is a downhill polymerization","volume":"43","author":"Hurshman","year":"2004","journal-title":"Biochemistry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"8276","DOI":"10.1021\/bi101280t","article-title":"Characterization of the interaction of \u03b2-Amyloid with Transthyretin monomers and tetramers","volume":"49","author":"Du","year":"2010","journal-title":"Biochemistry"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"19423","DOI":"10.1523\/JNEUROSCI.2561-13.2013","article-title":"Mechanisms of transthyretin inhibition of \u03b2-amyloid aggregation in vitro","volume":"33","author":"Li","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1021\/acs.jmedchem.9b01970","article-title":"Calorimetric Studies of Binary and Ternary Molecular Interactions between Transthyretin, A\u03b2 Peptides, and Small-Molecule Chaperones toward an Alternative Strategy for Alzheimer\u2019s Disease Drug Discovery","volume":"63","author":"Cotrina","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.jmb.2018.06.005","article-title":"Transthyretin Interferes with A\u03b2 Amyloid Formation by Redirecting Oligomeric Nuclei into Non-Amyloid Aggregates","volume":"430","author":"Nilsson","year":"2018","journal-title":"J. Mol. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.febslet.2008.02.034","article-title":"Transthyretin binding to A-Beta peptide - Impact on A-Beta fibrillogenesis and toxicity","volume":"582","author":"Costa","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1750-1326-6-79","article-title":"Transthyretin and the brain re-visited: Is neuronal synthesis of transthyretin protective in Alzheimer\u2019s disease?","volume":"6","author":"Li","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.bbadis.2013.09.011","article-title":"Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro","volume":"1832","author":"Cascella","year":"2013","journal-title":"Biochim. Biophys. Acta\u2014Mol. Basis Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/pro.3396","article-title":"Inhibition of amyloid beta fibril formation by monomeric human transthyretin","volume":"27","author":"Garai","year":"2018","journal-title":"Protein Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0009-8981(91)90344-C","article-title":"A sensitive assay of transthyretin (prealbumin) in human cerebrospinal fluid in nanogram amounts by ELISA","volume":"197","author":"Vatassery","year":"1991","journal-title":"Clin. Chim. Acta"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1172\/JCI106741","article-title":"The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma","volume":"50","author":"Smith","year":"1971","journal-title":"J. Clin. Invest."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS \u03b2-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/jnnp.63.4.506","article-title":"Cerebrospinal fluid transthyretin: Aging and late onset Alzheimer\u2019s disease","volume":"63","author":"Serot","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JAD-2011-102145","article-title":"Human serum transthyretin levels correlate inversely with Alzheimer\u2019s disease","volume":"25","author":"Han","year":"2011","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1021\/acs.jmedchem.7b00428","article-title":"Insights on the Interaction between Transthyretin and A\u03b2 in Solution. A Saturation Transfer Difference (STD) NMR Analysis of the Role of Iododiflunisal","volume":"60","author":"Gimeno","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_63","first-page":"146","article-title":"Interaction of transthyretin with amyloid \u03b2-protein: Binding and inhibition of amyloid formation","volume":"199","author":"Schwarzman","year":"1996","journal-title":"CIBA Found. Symp."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/protein\/gzs026","article-title":"Identification of beta-amyloid-binding sites on transthyretin","volume":"25","author":"Du","year":"2012","journal-title":"Protein Eng. Des. Sel."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Baker, J.D., Shelton, L.B., Zheng, D., Favretto, F., Nordhues, B.A., Darling, A., Sullivan, L.E., Sun, Z., Solanki, P.K., and Martin, M.D. (2017). Human cyclophilin 40 unravels neurotoxic amyloids. PLOS Biol., 15.","DOI":"10.1371\/journal.pbio.2001336"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"145101","DOI":"10.1063\/1.5019457","article-title":"Molecular dynamics simulations of site point mutations in the TPR domain of cyclophilin 40 identify conformational states with distinct dynamic and enzymatic properties","volume":"148","author":"Gur","year":"2018","journal-title":"J. Chem. Phys."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/3-540-29717-0_16","article-title":"Chemical chaperones: Mechanisms of action and potential use","volume":"172","author":"Papp","year":"2006","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kushwah, N., Jain, V., and Yadav, D. (2020). Osmolytes: A possible therapeutic molecule for ameliorating the neurodegeneration caused by protein misfolding and aggregation. Biomolecules, 10.","DOI":"10.3390\/biom10010132"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MOL.0000000000000303","article-title":"Bile salts in control of lipid metabolism","volume":"27","author":"Schonewille","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fnagi.2016.00263","article-title":"Bile acids in neurodegenerative disorders","volume":"8","author":"Ackerman","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1021\/acschemneuro.9b00482","article-title":"Biophysical Elucidation of Amyloid Fibrillation Inhibition and Prevention of Secondary Nucleation by Cholic Acid: An Unexplored Function of Cholic Acid","volume":"10","author":"Majid","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12035-012-8256-y","article-title":"TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-\u03b2 deposition in APP\/PS1 mice","volume":"45","author":"Nunes","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2012.09.003","article-title":"Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP\/PS1 mice","volume":"50","author":"Lo","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbadis.2008.05.005","article-title":"Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy","volume":"1782","author":"Macedo","year":"2008","journal-title":"Biochim. Biophys. Acta\u2014Mol. Basis Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-8-74","article-title":"Synergy of combined Doxycycline\/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: Studies in FAP mouse models","volume":"8","author":"Cardoso","year":"2010","journal-title":"J. Transl. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/13506129.2012.678508","article-title":"Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: A phase II study","volume":"19","author":"Obici","year":"2012","journal-title":"Amyloid"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/13506129.2016.1269739","article-title":"Effect of doxycycline and ursodeoxycholic acid on transthyretin amyloidosis","volume":"24","author":"Wixner","year":"2017","journal-title":"Amyloid"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cardfail.2019.01.006","article-title":"Clinical Experience With the Use of Doxycycline and Ursodeoxycholic Acid for the Treatment of Transthyretin Cardiac Amyloidosis","volume":"25","author":"Karlstedt","year":"2019","journal-title":"J. Card. Fail."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.physiol.59.1.365","article-title":"Specific, Nongenomic Actions of Steroid Hormones","volume":"59","author":"Wehling","year":"1997","journal-title":"Annu. Rev. Physiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40119-022-00265-7","article-title":"Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"11","author":"Campbell","year":"2022","journal-title":"Cardiol. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jchf.2021.05.005","article-title":"Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS","volume":"9","author":"Caponetti","year":"2021","journal-title":"JACC Hear. Fail."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson\u2019s Disease: Variation by Age, Gender, and Race\/Ethnicity","volume":"157","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.yhbeh.2012.04.006","article-title":"Gender, sex steroid hormones, and Alzheimer\u2019s disease","volume":"63","author":"Vest","year":"2013","journal-title":"Horm. Behav."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbrc.2007.05.158","article-title":"Estrogen has anti-amyloidogenic effects on Alzheimer\u2019s \u03b2-amyloid fibrils in vitro","volume":"359","author":"Morinaga","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.expneurol.2009.03.003","article-title":"Anti-aggregation and fibril-destabilizing effects of sex hormones on \u03b1-synuclein fibrils in vitro","volume":"217","author":"Hirohata","year":"2009","journal-title":"Exp. Neurol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fnins.2020.00157","article-title":"The Effect of Estrogen Replacement Therapy on Alzheimer\u2019s Disease and Parkinson\u2019s Disease in Postmenopausal Women: A Meta-Analysis","volume":"14","author":"Song","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1046\/j.1471-4159.1996.66051836.x","article-title":"Estrogens Attenuate and Corticosterone Exacerbates Excitotoxicity, Oxidative Injury, and Amyloid \u03b2-Peptide Toxicity in Hippocampal Neurons","volume":"66","author":"Goodman","year":"1996","journal-title":"J. Neurochem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1046\/j.1471-4159.2000.0751447.x","article-title":"Estrogen Enhances Uptake of Amyloid \u03b2-Protein by Microglia Derived from the Human Cortex","volume":"75","author":"Li","year":"2002","journal-title":"J. Neurochem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1196\/annals.1386.004","article-title":"Implications for Estrogens in Parkinson\u2019s Disease: An Epidemiological Approach","volume":"1089","author":"Ragonese","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/s-2005-869485","article-title":"Estrogen and cognition, with a focus on Alzheimer\u2019s disease","volume":"23","author":"Pinkerton","year":"2005","journal-title":"Semin. Reprod. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.abb.2012.04.021","article-title":"Trehalose inhibits fibrillation of A53T mutant alpha-synuclein and disaggregates existing fibrils","volume":"523","author":"Yu","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2005.02.003","article-title":"Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42","volume":"20","author":"Liu","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s10930-017-9705-2","article-title":"Trehalose and Magnesium Chloride Exert a Common Anti-amyloidogenic Effect Towards Hen Egg White Lysozyme","volume":"36","author":"Chatterjee","year":"2017","journal-title":"Protein J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1074\/jbc.M113.501635","article-title":"Scyllo-Inositol promotes Robust Mutant Huntingtin Protein degradation","volume":"289","author":"Lai","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbrc.2015.12.043","article-title":"\u03b1-Synuclein aggregation, seeding and inhibition by scyllo-inositol","volume":"469","author":"Ibrahim","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm1423","article-title":"Cyclohexanehexol inhibitors of A\u03b2 aggregation prevent and reverse Alzheimer phenotype in a mouse model","volume":"12","author":"McLaurin","year":"2006","journal-title":"Nat. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.0b013e3182309fa5","article-title":"A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease","volume":"77","author":"Salloway","year":"2011","journal-title":"Neurology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00109-007-0156-7","article-title":"Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology","volume":"85","author":"Fenili","year":"2007","journal-title":"J. Mol. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ana.21051","article-title":"Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-\u03b2 oligomers","volume":"60","author":"Townsend","year":"2006","journal-title":"Ann. Neurol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/B978-0-12-394816-8.00006-4","article-title":"Scyllo-Inositol, Preclinical, and Clinical Data for Alzheimer\u2019s Disease","volume":"Volume 64","author":"Ma","year":"2012","journal-title":"Advances in Pharmacology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/prot.22266","article-title":"The osmolyte betaine promotes protein misfolding and disruption of protein aggregates","volume":"75","author":"Natalello","year":"2009","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1379\/CSC-139R.1","article-title":"Native folding of aggregation-prone recombinant proteins in Escherichia coli by osmolytes, plasmid- or benzyl alcohol-overexpressed molecular chaperones","volume":"10","author":"Vigh","year":"2005","journal-title":"Cell Stress Chaperones"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0006-2952(03)00002-9","article-title":"Multidisciplinary utilization of dimethyl sulfoxide: Pharmacological, cellular, and molecular aspects","volume":"65","author":"Santos","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2008.11.006","article-title":"Dimethyl sulfoxide (DMSO) produces widespread apoptosis in the developing central nervous system","volume":"34","author":"Hanslick","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jnr.21477","article-title":"Modulation of brain metabolism by very low concentrations of the commonly used drug delivery vehicle dimethyl sulfoxide (DMSO)","volume":"86","author":"Nasrallah","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.brainres.2004.02.037","article-title":"Diazoxide and dimethyl sulphoxide prevent cerebral hypoperfusion-related learning dysfunction and brain damage after carotid artery occlusion","volume":"1008","author":"Farkas","year":"2004","journal-title":"Brain Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jb\/mvg124","article-title":"Dissolution of 2-Microglobulin Amyloid Fibrils by Dimethylsulfoxide","volume":"134","year":"2003","journal-title":"J. Biochem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1021\/bi900394b","article-title":"Noncooperative dimethyl sulfoxide-induced dissection of insulin fibrils: Toward soluble building blocks of amyloid","volume":"48","author":"Loksztejn","year":"2009","journal-title":"Biochemistry"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1021\/jp5037348","article-title":"Comparative study of protein unfolding in aqueous urea and dimethyl sulfoxide solutions: Surface polarity, solvent specificity, and sequence of secondary structure melting","volume":"118","author":"Roy","year":"2014","journal-title":"J. Phys. Chem. B"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40120-016-0040-x","article-title":"Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis","volume":"5","author":"Coelho","year":"2016","journal-title":"Neurol. Ther."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1039\/C4CP04549A","article-title":"A look into amyloid formation by transthyretin: Aggregation pathway and a novel kinetic model","volume":"17","author":"Faria","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Jesus, C.S.H., Almeida, Z.L., Vaz, D.C., Faria, T.Q., and Brito, R.M.M. (2016). A new folding kinetic mechanism for human transthyretin and the influence of the amyloidogenic V30M mutation. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091428"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-18443-2","article-title":"Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids","volume":"8","author":"KrishnaKumar","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1021\/acschemneuro.9b00123","article-title":"Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer\u2019s Disease and Type-2 Diabetes","volume":"10","author":"Paul","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Viswanathan, G.K., Paul, A., Gazit, E., and Segal, D. (2019). Naphthoquinone Tryptophan Hybrids: A Promising Small Molecule Scaffold for Mitigating Aggregation of Amyloidogenic Proteins and Peptides. Front. Cell Dev. Biol., 1\u201310.","DOI":"10.3389\/fcell.2019.00242"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jmb.2005.04.016","article-title":"Prediction of \u201caggregation-prone\u201d and \u201caggregation- susceptible\u201d regions in proteins associated with neurodegenerative diseases","volume":"350","author":"Pawar","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Scherzer-Attali, R., Pellarin, R., Convertino, M., Frydman-Marom, A., Egoz-Matia, N., Peled, S., Levy-Sakin, M., Shalev, D.E., Caflisch, A., and Gazit, E. (2010). Complete phenotypic recovery of an Alzheimer\u2019s disease model by a quinone-tryptophan hybrid aggregation inhibitor. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011101"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fmolb.2019.00016","article-title":"Novel Mannitol-Based Small Molecules for Inhibiting Aggregation of \u03b1-Synuclein Amyloids in Parkinson\u2019s Disease","volume":"6","author":"Paul","year":"2019","journal-title":"Front. Mol. Biosci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/prot.24080","article-title":"Generic inhibition of amyloidogenic proteins by two naphthoquinone-tryptophan hybrid molecules","volume":"80","author":"Adalist","year":"2012","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"ref_120","first-page":"1","article-title":"Drug Solubility: Importance and Enhancement Techniques","volume":"2012","author":"Savjani","year":"2012","journal-title":"ISRN Pharm."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.chembiol.2013.09.010","article-title":"Glycotherapy: New advances inspire a reemergence of glycans in medicine","volume":"21","author":"Hudak","year":"2014","journal-title":"Chem. Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-020-01216-5","article-title":"Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of A\u03b242 and hIAPP peptides while reducing their toxicity","volume":"3","author":"Paul","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/13506129.2011.582902","article-title":"The generic amyloid formation inhibition effect of a designed small aromatic \u03b2-breaking peptide","volume":"18","author":"Moshe","year":"2011","journal-title":"Amyloid"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1096\/fj.01-0442hyp","article-title":"A possible role for \u03c0-stacking in the self-assembly of amyloid fibrils","volume":"16","author":"Gazit","year":"2002","journal-title":"FASEB J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1039\/C8FO01569D","article-title":"Health functions and structure-activity relationships of natural anthraquinones from plants","volume":"9","author":"Li","year":"2018","journal-title":"Food Funct."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Nam, W., Kim, S., Nam, S., and Friedman, M. (2017). Structure-Antioxidative and Anti-Inflammatory Activity Relationships of Purpurin and Related Anthraquinones in Chemical and Cell Assays. Molecules, 22.","DOI":"10.3390\/molecules22020265"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1007\/s00018-019-03312-0","article-title":"Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer\u2019s disease-like symptoms in animal model","volume":"77","author":"Viswanathan","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1074\/jbc.M410984200","article-title":"Anthraquinones inhibit tau aggregation and dissolve Alzheimer\u2019s paired helical filaments in vitro and in cells","volume":"280","author":"Pickhardt","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1038\/srep05648","article-title":"Effects of several quinones on insulin aggregation","volume":"4","author":"Gong","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1039\/C4NP00027G","article-title":"Structural diversity and bioactivities of natural benzophenones","volume":"31","author":"Wu","year":"2014","journal-title":"Nat. Prod. Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/cbic.201100123","article-title":"Polyphenolic Glycosides and Aglycones Utilize Opposing Pathways To Selectively Remodel and Inactivate Toxic Oligomers of Amyloid \u03b2","volume":"12","author":"Ladiwala","year":"2011","journal-title":"ChemBioChem"},{"key":"ref_132","unstructured":"Castillo, G.M., Choi, P.Y., and Snow, A.D. (2000). Polyhydroxylated Aromatic Compounds for The Treatment of Amyloidosis and \u0391-Synuclein Fibril Diseases. (WO2001049281A2)."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41702-020-0057-8","article-title":"Activity of catechins and their applications","volume":"4","author":"Bae","year":"2020","journal-title":"Biomed. Dermatology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-3-319-18365-7_7","article-title":"The effect of (-)-epigallo-catechin-(3)-gallate on amyloidogenic proteins suggests a common mechanism","volume":"863","author":"Andrich","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"62402","DOI":"10.1039\/C5RA09608A","article-title":"Structural characteristics of (-)-epigallocatechin-3-gallate inhibiting amyloid A\u03b242 aggregation and remodeling amyloid fibers","volume":"5","author":"Liu","year":"2015","journal-title":"RSC Adv."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1021\/bi2015162","article-title":"Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols","volume":"51","author":"Cao","year":"2012","journal-title":"Biochemistry"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"11391","DOI":"10.1021\/jf902664f","article-title":"Tea catechins induce the conversion of preformed lysozyme amyloid fibrils to amorphous aggregates. J. Agric","volume":"57","author":"Jing","year":"2009","journal-title":"Food Chem."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/acschemneuro.0c00277","article-title":"Green Tea Extracts EGCG and EGC Display Distinct Mechanisms in Disrupting A\u03b242Protofibril","volume":"11","author":"Zhan","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bpj.2020.05.033","article-title":"The Effect of (\u2212)-Epigallocatechin-3-Gallate on the Amyloid-\u03b2 Secondary Structure","volume":"119","author":"Acharya","year":"2020","journal-title":"Biophys. J."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1039\/D1CP01913A","article-title":"Molecular mechanisms of resveratrol and EGCG in the inhibition of A\u03b242aggregation and disruption of A\u03b242protofibril: Similarities and differences","volume":"23","author":"Li","year":"2021","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1021\/acschemneuro.0c00598","article-title":"Epigallocatechin Gallate Destabilizes \u03b1-Synuclein Fibril by Disrupting the E46-K80 Salt-Bridge and Inter-protofibril Interface","volume":"11","author":"Yao","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Seidler, P., Boyer, D., Sawaya, M., Ge, P., Shin, W., DeTure, M., Dickson, D., Jiang, L., and Eisenberg, D. (2020). CryoEM reveals how the small molecule EGCG binds to Alzheimer\u2019s brain-derived tau fibrils and initiates fibril disaggregation. bioRxiv.","DOI":"10.1101\/2020.05.29.124537"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/pro.3549","article-title":"Suppression, disaggregation, and modulation of \u03b3-Synuclein fibrillation pathway by green tea polyphenol EGCG","volume":"28","author":"Roy","year":"2019","journal-title":"Protein Sci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00392-012-0463-z","article-title":"Green tea halts progression of cardiac transthyretin amyloidosis: An observational report","volume":"101","author":"Kristen","year":"2012","journal-title":"Clin. Res. Cardiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s00392-015-0826-3","article-title":"Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: Preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study","volume":"104","author":"Buss","year":"2015","journal-title":"Clin. Res. Cardiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11739-018-1887-x","article-title":"Epigallocatechin-3-gallate tolerability and impact on survival in a cohort of patients with transthyretin-related cardiac amyloidosis. A single-center retrospective study","volume":"13","author":"Cappelli","year":"2018","journal-title":"Intern. Emerg. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.fshw.2022.03.002","article-title":"Green tea, epigallocatechin gallate and the prevention of Alzheimer\u2019s disease: Clinical evidence","volume":"11","author":"Lange","year":"2022","journal-title":"Food Sci. Hum. Wellness"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/acschemneuro.0c00381","article-title":"Potential role of natural polyphenols against protein aggregation toxicity: In vitro, in vivo, and clinical studies","volume":"11","author":"Narayan","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/acs.jnatprod.5b00947","article-title":"Feeling Nature\u2019s PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)","volume":"79","author":"Baell","year":"2016","journal-title":"J. Nat. Prod."},{"key":"ref_150","first-page":"33","article-title":"Adriamycin (NSC-123,127): A new antibiotic with antitumor activity","volume":"53","year":"1969","journal-title":"Cancer Chemother. Rep."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/bit.260110607","article-title":"Adriamycin, 14-hydroxydaimomycin, a new antitumor antibiotic fromS. Peucetius var.caesius","volume":"11","author":"Arcamone","year":"1969","journal-title":"Biotechnol. Bioeng."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Post, C., Tagliavini, F., McArthur, R.A., Della Vedova, F., Gerna, M., Bandiera, T., Varasi, M., Molinari, A., and Lansen, J. (1998). Anthracyclines and Amyloidosis. Advances in Behavioral Biology, Springer.","DOI":"10.1007\/978-1-4615-5337-3_29"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1021\/jm400161p","article-title":"A new face for old antibiotics: Tetracyclines in treatment of amyloidoses","volume":"56","author":"Stoilova","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0014-5793(00)02380-2","article-title":"Anti-amyloidogenic activity of tetracyclines: Studies in vitro","volume":"487","author":"Forloni","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.2006.03707.x","article-title":"Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro","volume":"97","author":"Ono","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/jnr.21271","article-title":"Anti-fibrillogenic and fibril-destabilizing activities of anti-Parkinsonian agents for \u03b1-synuclein fibrils in vitro","volume":"85","author":"Ono","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1096\/fj.02-0764com","article-title":"4 \u2032-iodo-4\u2032-Deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: Screening for TTR fibril disrupters","volume":"17","author":"Cardoso","year":"2003","journal-title":"FASEB J."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1096\/fj.05-4509com","article-title":"Doxycycline disrupts transthyretin amyloid: Evidence from studies in a FAP transgenic mice model","volume":"20","author":"Cardoso","year":"2006","journal-title":"FASEB J."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1074\/jbc.M110.178376","article-title":"Effect of tetracyclines on the dynamics of formation and destructuration of \u03b22-microglobulin amyloid fibrils","volume":"286","author":"Giorgetti","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1042\/bj20030422","article-title":"Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid","volume":"374","author":"Aitken","year":"2003","journal-title":"Biochem. J."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biochi.2020.04.012","article-title":"Tetracycline derivatives resist the assembly behavior of human islet amyloid polypeptide","volume":"174","author":"Xu","year":"2020","journal-title":"Biochimie"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1182\/blood-2011-04-351643","article-title":"Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis","volume":"118","author":"Ward","year":"2011","journal-title":"Blood"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1006\/jmbi.2000.3840","article-title":"Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro","volume":"300","author":"Tagliavini","year":"2000","journal-title":"J. Mol. Biol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ana.10614","article-title":"Minocycline and doxycycline are not beneficial in a model of Huntington\u2019s disease","volume":"54","author":"Smith","year":"2003","journal-title":"Ann. Neurol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11899-009-0013-6","article-title":"Treatment of immunoglobulin light chain amyloidosis","volume":"4","author":"Gertz","year":"2009","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/bj3510273","article-title":"The molecular interaction of 4\u2032-iodo-4\u2032-deoxydoxorubicin with Leu-55Pro transthyretin \u2018amyloid-like\u2019 oligomer leading to disaggregation","volume":"351","author":"MERLINI","year":"2000","journal-title":"Biochem. J."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood.V86.3.855.855","article-title":"New drug therapy of amyloidoses: Resorption of AL-type deposits with 4\u2019- iodo-4\u2019-deoxydoxorubicin","volume":"86","author":"Gianni","year":"1995","journal-title":"Blood"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1073\/pnas.92.7.2959","article-title":"Interaction of the anthracycline 4\u2019-iodo-4\u2019-deoxydoxorubicin with amyloid fibrils: Inhibition of amyloidogenesis","volume":"92","author":"Merlini","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.5301\/JBM.5000041","article-title":"Role of the renin-angiotensin-aldosterone system and the glutathione S-transferase Mu, Pi and Theta gene polymorphisms in cardiotoxicity after anthracycline chemotherapy for breast carcinoma","volume":"28","author":"Vivenza","year":"2013","journal-title":"Int. J. Biol. Markers"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1042\/CS20200301","article-title":"Molecular mechanisms of anthracycline cardiovascular toxicity","volume":"135","author":"Narezkina","year":"2021","journal-title":"Clin. Sci."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Gautieri, A., Beeg, M., Gobbi, M., Rigoldi, F., Colombo, L., and Salmona, M. (2019). The Anti-Amyloidogenic Action of Doxycycline: A Molecular Dynamics Study on the Interaction with A\u03b242. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184641"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Andes, D., and Craig, W.A. (2007). Pharmacokinetics and Pharmacodynamics of Tetracyclines. Antimicrobial Pharmacodynamics in Theory and Clinical Practice, CRC Press. [2nd ed.].","DOI":"10.3109\/9781420017137.013"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2165\/00003088-200241060-00004","article-title":"Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs","volume":"41","author":"Danesi","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2885.2004.00617.x","article-title":"Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest","volume":"27","author":"Lees","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/labinvest.3700059","article-title":"Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants","volume":"84","author":"Miller","year":"2004","journal-title":"Lab. Investig."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: A randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/13506129.2014.997872","article-title":"Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis","volume":"22","author":"Sekijima","year":"2015","journal-title":"Amyloid"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/13506129.2018.1519507","article-title":"Diflunisal tolerability in transthyretin cardiac amyloidosis: A single center\u2019s experience","volume":"25","author":"Ikram","year":"2018","journal-title":"Amyloid"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jns.2014.07.017","article-title":"Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area","volume":"345","author":"Takahashi","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.neuropharm.2005.07.004","article-title":"Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer\u2019s \u03b2-amyloid fibrils in vitro","volume":"49","author":"Hirohata","year":"2005","journal-title":"Neuropharmacology"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.neuropharm.2007.11.010","article-title":"Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for \u03b1-synuclein fibrils in vitro","volume":"54","author":"Hirohata","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1080\/07391102.2017.1338164","article-title":"NSAIDs as potential treatment option for preventing amyloid \u03b2 toxicity in Alzheimer\u2019s disease: An investigation by docking, molecular dynamics, and DFT studies","volume":"36","author":"Azam","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/WAD.0000000000000098","article-title":"NSAID Use and Incident Cognitive Impairment in a Population-based Cohort","volume":"30","author":"Wichmann","year":"2016","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1212\/WNL.0b013e3181a18691","article-title":"Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort","volume":"72","author":"Breitner","year":"2009","journal-title":"Neurology"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/sj.npp.1300690","article-title":"A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment","volume":"30","author":"Thal","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11481-011-9312-5","article-title":"Non-steroidal anti-inflammatory drugs and cognitive function: Are prostaglandins at the heart of cognitive impairment in dementia and delirium?","volume":"7","author":"Cunningham","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1021\/acs.accounts.5b00507","article-title":"Phthalocyanines as Molecular Scaffolds to Block Disease-Associated Protein Aggregation","volume":"49","author":"Miotto","year":"2016","journal-title":"Acc. Chem. Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/0929866526666190307164944","article-title":"Inhibition of Amyloid Fibrillation by Small Molecules and Nanomaterials: Strategic Development of Pharmaceuticals Against Amyloidosis","volume":"26","author":"Sharma","year":"2019","journal-title":"Protein Pept. Lett."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Gour, N., and Koshti, B. (2019). A Chemical Perspective to the Anti-Amyloid Action of Compounds and a Nanoparticle Based Assay for Screening Amyloid Inhibitors. ChemRxiv.","DOI":"10.26434\/chemrxiv.7819661"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbrc.2014.10.062","article-title":"Hemin as a generic and potent protein misfolding inhibitor","volume":"454","author":"Liu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bbapap.2017.07.017","article-title":"Hemin is able to disaggregate lysozyme amyloid fibrils into monomers","volume":"1865","author":"Sonavane","year":"2017","journal-title":"Biochim. Biophys. Acta\u2014Proteins Proteomics"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1021\/tx300441e","article-title":"A\u03b2 interacts with both the iron center and the porphyrin ring of heme: Mechanism of heme\u2019s action on A\u03b2 aggregation and disaggregation","volume":"26","author":"Yuan","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M408714200","article-title":"Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins","volume":"280","author":"Taniguchi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","article-title":"Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines","volume":"93","author":"Wischik","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"e2811","DOI":"10.1002\/jmr.2811","article-title":"Study of tetraphenylporphyrins as modifiers of insulin amyloid aggregation","volume":"33","author":"Chernii","year":"2020","journal-title":"J. Mol. Recognit."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"23518","DOI":"10.1074\/jbc.M113.470450","article-title":"Formation of dynamic soluble surfactant-induced amyloid \u03b2 peptide aggregation intermediates","volume":"288","author":"Abelein","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1021\/la050472x","article-title":"Stimulatory and inhibitory effects of alkyl bromide surfactants on \u03b2-amyloid fibrillogenesis","volume":"21","author":"Estelrich","year":"2005","journal-title":"Langmuir"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbadis.2005.05.004","article-title":"Inhibition of amyloid fibril formation of \u03b2-amyloid peptides via the amphiphilic surfactants","volume":"1741","author":"Wang","year":"2005","journal-title":"Biochim. Biophys. Acta\u2014Mol. Basis Dis."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijbiomac.2013.04.014","article-title":"Effect of surfactants on preformed fibrils of human serum albumin","volume":"59","author":"Pandey","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"58616","DOI":"10.1039\/C5RA08923A","article-title":"Modulation of bovine serum albumin fibrillation by ester bonded and conventional gemini surfactants","volume":"5","author":"Yaseen","year":"2015","journal-title":"RSC Adv."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ijbiomac.2016.08.082","article-title":"In vitro disintegration of goat brain cystatin fibrils using conventional and gemini surfactants: Putative therapeutic intervention in amyloidoses","volume":"93","author":"Bhat","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1021\/la9042974","article-title":"Facile disassembly of amyloid fibrils using gemini surfactant micelles","volume":"26","author":"Han","year":"2010","journal-title":"Langmuir"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/la200350j","article-title":"Disassembly of amyloid fibrils by premicellar and micellar aggregates of a tetrameric cationic surfactant in aqueous solution","volume":"27","author":"He","year":"2011","journal-title":"Langmuir"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"9298","DOI":"10.1021\/jp503282m","article-title":"Disaggregation ability of different chelating molecules on copper ion-triggered amyloid fibers","volume":"118","author":"Zhu","year":"2014","journal-title":"J. Phys. Chem. B"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/1521-3773(20000602)39:11<1906::AID-ANIE1906>3.0.CO;2-Q","article-title":"Gemini Surfactants","volume":"39","author":"Menger","year":"2000","journal-title":"Angew. Chemie Int. Ed."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1246\/bcsj.45.428","article-title":"The Second CMC of the Aqueous Solution of Sodium Dodecyl Sulfate. I. Conductivity","volume":"45","author":"Miura","year":"1972","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/la903672r","article-title":"Aggregation behavior of a tetrameric cationic surfactant in aqueous solution","volume":"26","author":"Hou","year":"2010","journal-title":"Langmuir"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.molliq.2016.07.098","article-title":"Micellization of cationic surfactants in alcohol \u2014 water mixed solvent media","volume":"222","author":"Shah","year":"2016","journal-title":"J. Mol. Liq."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2174\/092986709787002808","article-title":"Gemini Surfactant Based Carriers in Gene and Drug Delivery","volume":"16","author":"Bombelli","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/anie.200201597","article-title":"Gemini Surfactants: New Synthetic Vectors for Gene Transfection","volume":"42","author":"Kirby","year":"2003","journal-title":"Angew. Chemie Int. Ed."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"11119","DOI":"10.1073\/pnas.0901422106","article-title":"Ultrasonication-dependent production and breakdown lead to minimum-sized amyloid fibrils","volume":"106","author":"Chatani","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1002\/anie.201403815","article-title":"Cold Denaturation of \u03b1-Synuclein Amyloid Fibrils","volume":"53","author":"Ikenoue","year":"2014","journal-title":"Angew. Chemie Int. Ed."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1110\/ps.04823504","article-title":"Insulin amyloid fibrillation at above 100 \u00b0C: New insights into protein folding under extreme temperatures","volume":"13","author":"Arora","year":"2004","journal-title":"Protein Sci."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1365-3083.1999.00508.x","article-title":"Fourier Transform Infrared Spectroscopic Investigation of Temperature- and Pressure-Induced Disaggregation of Amyloid A","volume":"49","author":"Dubois","year":"1999","journal-title":"Scand. J. Immunol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0076-6879(06)13013-X","article-title":"High-Pressure Studies on Protein Aggregates and Amyloid Fibrils","volume":"413","author":"Kim","year":"2006","journal-title":"Methods Enzymol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/12\/3276\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:43:23Z","timestamp":1760147003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/12\/3276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":215,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["biomedicines10123276"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10123276","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,17]]}}}